Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

1.69
-0.0900-5.06%
Post-market: 1.690.00000.00%19:51 EDT
Volume:506.45K
Turnover:862.18K
Market Cap:51.22M
PE:-2.12
High:1.80
Open:1.80
Low:1.65
Close:1.78
Loading ...
Jun 09, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 09, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 20, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 20, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 20, 2023

Major Issues Report

8-K - Current report
Apr 18, 2023

Correspondence

Form CORRESP - Correspondence
Apr 18, 2023

Correspondence

Form CORRESP - Correspondence
Apr 18, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 18, 2023

Major Issues Report

8-K - Current report
Apr 11, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 11, 2023

Major Issues Report

8-K - Current report